Analyst firms · Deutsche Bank · CL
Deutsche Bank CL price target and rating history
Colgate-Palmolive Company (CL) · Consumer Discretionary
Deutsche Bank rates Colgate-Palmolive Company (CL) Buy with a $98 price target, as of its latest action on Mar 30, 2026. It has published 5 rating actions on CL since August 2021, including 2 upgrades and 1 downgrade. Across 7 firms with a CL price target in the last 12 months, the median target is $88. Deutsche Bank's $98 is 11% above that.
- Current rating
- Buy
- Price target
- $98
- Median target, all firms
- $88
- Actions on CL
- 5
Deutsche Bank price target on CL
Every Deutsche Bank rating on CL
- Mar 30, 2026
- Sep 9, 2024
- Jan 31, 2022
- Sep 20, 2021
- Aug 2, 2021
How other firms rate CL
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Bernstein | Mkt Perform | $96 | Jun 12, 2026 |
| Rothschild & Co Redburn | Buy | $100 | Apr 21, 2026 |
| TD Cowen | Hold | $85 | Mar 31, 2026 |
| Deutsche Bank | Buy | $98 | Mar 30, 2026 |
| Wells Fargo | Equal Weight | $86 | Jan 13, 2026 |
| Piper Sandler | Overweight | $88 | Jan 7, 2026 |
| Argus Research | Hold | Dec 11, 2025 | |
| RBC Capital Markets | Outperform | $88 | Dec 9, 2025 |
Questions about Deutsche Bank and CL
- What is Deutsche Bank's price target for CL?
- Deutsche Bank's latest stated price target for Colgate-Palmolive Company (CL) is $98, from its action on Mar 30, 2026.
- What is Deutsche Bank's rating on CL?
- Deutsche Bank rates CL Buy, a bullish rating, as of Mar 30, 2026.
- When did Deutsche Bank last change its view on CL?
- On Mar 30, 2026, Deutsche Bank upgrades to Buy from Hold, price target $98.
- How does Deutsche Bank's CL target compare with other analysts?
- Across 7 firms with a CL price target in the last 12 months, the median target is $88. Deutsche Bank's $98 is 11% above that.
More CL rating histories
All Deutsche Bank ratingsCL news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.